Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
AMUSE, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 2.6 times, Exceeds Full-Year Plan
4301 AMUSE INC. 【J-GAAP】
Earnings ReportAMUSE INC. <4301> [TSE Prime] announced its financial results after the market closed on February 14th (15:45). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) surged 2.6 times that of the same period last year, reaching 2.84 billion yen. The progress rate toward the full-year plan of 1.8 billion yen is 158.2%, already exceeding the target and also exceeding the five-year average of 89.8%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit/loss for the January to March period (4Q) is expected to turn into a loss of 1.04 billion yen (compared to a profit of 0.69 billion yen in the same period last year).
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit decreased to 0.83 billion yen, a 10.6% decrease compared to the same period last year. The operating profit margin worsened from 4.7% in the same period last year to 4.3%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 38,445 | 2,366 | 2,584 | 1,399 | 82.7 | 76.5 | Feb 14, 2023 | J-GAAP |
Apr - Dec, 2023 | 39,716 | 797 | 1,080 | 361 | 21.8 | 60.8 | Feb 14, 2024 | J-GAAP |
Apr - Dec, 2024 | 53,887 | 2,660 | 2,847 | 617 | 37.2 | 158.2 | Feb 14, 2025 | J-GAAP |
YoY | +35.7% | +233.8% | +163.6% | +70.9% | +70.3% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 31,880 | 1,351 | 1,636 | 554 | 33.5 | 20 | May 15, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 22,765 | -244 | -208 | 190 | 11.4 | 20 | Nov 14, 2024 | J-GAAP |
YoY | -28.6% | - | - | -65.7% | -65.8% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 52,497 | 3,153 | 3,379 | 1,692 | 100.6 | 40 | May 15, 2023 | J-GAAP |
Mar, 2024 | 54,813 | 1,367 | 1,777 | 391 | 23.6 | 40 | May 15, 2024 | J-GAAP |
Mar, 2025 Guidance | 60,000 | 1,700 | 1,800 | 350 | 21.1 | 40 | May 15, 2024 | J-GAAP |
YoY | +9.5% | +24.4% | +1.3% | -10.5% | -10.7% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 16,783 | 781 | 939 | 524 | 31.7 | 4.7 | Feb 14, 2024 | J-GAAP |
Jan - Mar, 2024 | 15,097 | 570 | 697 | 30 | 1.8 | 3.8 | May 15, 2024 | J-GAAP |
Apr - Jun, 2024 | 17,646 | 879 | 964 | 135 | 8.2 | 5.0 | Aug 14, 2024 | J-GAAP |
Jul - Sep, 2024 | 19,589 | 1,065 | 1,044 | 25 | 1.5 | 5.4 | Nov 14, 2024 | J-GAAP |
Oct - Dec, 2024 | 16,652 | 716 | 839 | 457 | 27.5 | 4.3 | Feb 14, 2025 | J-GAAP |
YoY | -0.8% | -8.3% | -10.6% | -12.8% | -13.1% |
Related Articles
HIRAYAMA HOLDINGS, Oct-Dec (2Q) Ordinary Profit Decreases by 4%
Writeup, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 3.5 times, Oct-Dec Ordinary Profit Increases by 2.3 times
TRADE WORKS, Returning to Profitability This Year
KIKUSUI CHEMICAL, Oct-Dec (3Q) Ordinary Profit Decreases by 46%
DENTSU, Net Income/Loss Unexpectedly Turn to Loss for Last Fiscal Year, Returning to Profitability This Year
RaQualia Pharma, Returning to Profitability This Year
TOYO DRILUBE, First Half Ordinary Profit Increases by 25%, Oct-Dec Ordinary Profit Increases by 20%
MANDARAKE, Oct-Dec (1Q) Ordinary Profit Decreases by 45%
Oriental Consultants, Oct-Dec (1Q) Ordinary Profit Increases by 7.3 times
EBARA Foods Industry, The Current Fiscal Year Ordinary Profit Revised Upward by 40%, Dividend Revised Upward by 5 yen